These findings suggested that abnormalities in CD28/CTLA-4-CD80/CD86 and PD-1-mediated signaling pathways may be involved in the pathogenic mechanism of γδ T cells in the progression of CAD. The gene discussed is CD86; the disease is coronary artery disorder.